435 related articles for article (PubMed ID: 6524872)
1. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.
Moser HW; Moser AE; Singh I; O'Neill BP
Ann Neurol; 1984 Dec; 16(6):628-41. PubMed ID: 6524872
[TBL] [Abstract][Full Text] [Related]
2. Stereological analysis of peroxisomes and mitochondria in intestinal epithelium of patients with peroxisomal deficiency disorders: Zellweger's syndrome and neonatal-onset adrenoleukodystrophy.
Black VH; Cornacchia L
Am J Anat; 1986 Sep; 177(1):107-18. PubMed ID: 3776884
[TBL] [Abstract][Full Text] [Related]
3. A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients.
Moser AB; Borel J; Odone A; Naidu S; Cornblath D; Sanders DB; Moser HW
Ann Neurol; 1987 Mar; 21(3):240-9. PubMed ID: 2440378
[TBL] [Abstract][Full Text] [Related]
4. [Examination of very long chain fatty acids in diagnosis of x-linked adrenoleukodystrophy].
Stradomska TJ; Tylki-Szymańska A
Pediatr Pol; 1996 Mar; 71(3):197-201. PubMed ID: 8966090
[TBL] [Abstract][Full Text] [Related]
5. The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis.
Moser AE; Singh I; Brown FR; Solish GI; Kelley RI; Benke PJ; Moser HW
N Engl J Med; 1984 May; 310(18):1141-6. PubMed ID: 6709009
[TBL] [Abstract][Full Text] [Related]
6. Adrenoleukodystrophy.
Lenard HG
Neuropediatrics; 1984 Sep; 15 Suppl():16-9. PubMed ID: 6100794
[TBL] [Abstract][Full Text] [Related]
7. [Adrenomyeloneuropathy: clinical, genetic and morphologic features. Apropos of 5 cases].
Rondot P; de Recondo J; Davous P; Dubas F; Khoubesserian P
Acta Neurol Belg; 1983; 83(5):246-60. PubMed ID: 6686915
[TBL] [Abstract][Full Text] [Related]
8. Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels.
Rizzo WB; Phillips MW; Dammann AL; Leshner RT; Jennings SS; Avigan J; Proud VK
Ann Neurol; 1987 Mar; 21(3):232-9. PubMed ID: 3037987
[TBL] [Abstract][Full Text] [Related]
9. [X-linked adrenoleukodystrophy and other peroxisomal diseases caused by a failing peroxisomal beta-oxidation system: clinical expression, diagnosis and treatment].
Wanders RJ; Barth PG; Schutgens RB; Van den Bosch H; Tager JM; Stroink H; Przyrembel H; Heymans HS
Tijdschr Kindergeneeskd; 1989 Oct; 57(5):186-97. PubMed ID: 2683204
[TBL] [Abstract][Full Text] [Related]
10. [Familial adrenoleukodystrophy].
Le Fur JM; Le Meur F; Parent P; Toudic L; Castel Y
J Genet Hum; 1985 Dec; 33(5):427-34. PubMed ID: 4093772
[TBL] [Abstract][Full Text] [Related]
11. Adrenoleukodystrophy in Israel: a genetic, clinical and biochemical study.
Chemke J; Lieberman E; Carmi R; Abarbanel Y; Costeff H; Goldhammer Y; Moser HW
Isr J Med Sci; 1984 Dec; 20(12):1123-32. PubMed ID: 6097565
[TBL] [Abstract][Full Text] [Related]
12. Clinical and genetic aspects of X-linked adrenoleukodystrophy.
Gärtner J; Braun A; Holzinger A; Roerig P; Lenard HG; Roscher AA
Neuropediatrics; 1998 Feb; 29(1):3-13. PubMed ID: 9553942
[TBL] [Abstract][Full Text] [Related]
13. Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes.
Kelley RI; Datta NS; Dobyns WB; Hajra AK; Moser AB; Noetzel MJ; Zackai EH; Moser HW
Am J Med Genet; 1986 Apr; 23(4):869-901. PubMed ID: 3515938
[TBL] [Abstract][Full Text] [Related]
14. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes.
Singh I; Moser AE; Moser HW; Kishimoto Y
Pediatr Res; 1984 Mar; 18(3):286-90. PubMed ID: 6728562
[TBL] [Abstract][Full Text] [Related]
15. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.
Moser HW; Moser AB; Kawamura N; Murphy J; Suzuki K; Schaumburg H; Kishimoto Y
Ann Neurol; 1980 Jun; 7(6):542-9. PubMed ID: 7436359
[TBL] [Abstract][Full Text] [Related]
16. Plasma polyenoic very-long-chain fatty acids in peroxisomal disease: biochemical discrimination of Zellweger's syndrome from other phenotypes.
Poulos A; Sharp P; Johnson D
Neurology; 1989 Jan; 39(1):44-7. PubMed ID: 2462697
[TBL] [Abstract][Full Text] [Related]
17. Adrenoleukodystrophy: from bedside to molecular biology.
Moser HW
J Child Neurol; 1987 Apr; 2(2):140-50. PubMed ID: 3598142
[TBL] [Abstract][Full Text] [Related]
18. Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids.
Brown FR; McAdams AJ; Cummins JW; Konkol R; Singh I; Moser AB; Moser HW
Johns Hopkins Med J; 1982 Dec; 151(6):344-51. PubMed ID: 7176294
[No Abstract] [Full Text] [Related]
19. [X-linked adrenoleukodystrophy--2 case reports].
Dumić M; Ille J; Plavsić V; Filipović-Grcić B; Vrljicak K; Barisić N; Roscher A
Lijec Vjesn; 1998; 120(1-2):19-23. PubMed ID: 9650481
[TBL] [Abstract][Full Text] [Related]
20. [Very long chain fatty acids in the pathogenesis, prenatal and postnatal diagnosis of X-linked adrenoleukodystrophy].
Grković S; Dordević M; Nikolić R; Zivancević-Simonović S; Puzigaća Z
Med Pregl; 2007; 60(7-8):401-3. PubMed ID: 17990810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
